MedPath

PROGESTERONE INJECTION, USP

PROGESTERONE INJECTION, USP

Approved
DIN Number

02531828

Drug Class

Human

Market Date

Apr 28, 2023

Company
HC

hikma canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02531828
AIG Number0106327001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G03DA04 PROGESTERONE
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular
AHFS Classification68:32.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

PROGESTERONEActive
Strength: 50 MG / ML
Monograph: PROGESTERONE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.